{"nct_id":"NCT02136134","title":"Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma","status":"COMPLETED","status_verified_date":"2025-08","start_date":"2014-08-15","start_date_type":"ACTUAL","primary_completion_date":"2016-01-11","primary_completion_date_type":"ACTUAL","completion_date":"2024-01-10","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["JNJ"]}